Ascendis stock falls as FDA delays TransCon PTH review
Grandparents Editorial/iStock via Getty Images Ascendis Pharma (ASND) announced Tuesday that the U.S. Food and Drug Administration (FDA) has postponed the timeline for completing its review of the company's experimental…